Advanced search
Search Results: 28 results for keyword "Traphaco".
Traphaco focuses on modern medicines and invests in EU-GMP factories
13-04-2024 14:51
Vietnam's top herbal pharmaceutical company Traphaco has delivered solid business results for 2023 despite global turbulence, heard the company's AGM on April 12.
Traphaco deepens footprint on green development journey
28-11-2023 15:29
Aside from making premium Oriental medicines, Traphaco has embarked on producing modern pharmaceutical products. Dao Thuy Ha, the company’s deputy general director, speaks with VIR's Phong Lan about the novel aspects of the company’s green development journey.
Traphaco: Sustainable development via a green value chain
21-11-2023 09:46
To realise its goal of sustainable development, Traphaco aims to establish a green value chain with an extensive distribution system to provide good quality, effective, and safe medicinal products.
Traphaco leverages sustainable values
28-04-2023 08:00
Traphaco has unveiled its new strategy to produce high-class products for traditional and modern medicines, reaffirming the quality and effectiveness of treatments in the Vietnamese market.
Overseas touch lends to pharma gains
29-07-2022 10:00
Vietnam’s pharma giants are growing with new strategies from foreign leadership, easing local doubts over the possible disappearance of local strong brands.
Innovating Vietnam's pharmaceutical sector
21-04-2022 14:33
Traphaco JSC not only posted positive business results in 2021 but also registered an impressive momentum in the first quarter with an expected after-tax profit of $3.6 million, an increase of 50 per cent compared to the previous year. The pharmaceutical firm also makes shareholders and investors highly appreciate its progress in innovation and creativity, especially its corporate restructuring strategy.
International investors scoop up major stakes in drugmakers
30-06-2021 14:20
Dealmaking and investment in pharmaceutical and healthcare businesses are increasing in scope as investors are vying for the controlling stake of key players.
Targets being tweaked by prepared pharma
09-06-2021 20:53
There remains caution over interruption in the ingredient supply chain in Vietnam’s lucrative pharmaceutical industry, but new strategies to intensify growth potential ahead will ensure pharma groups maintain their profitability moving forward.
Traphaco listed among Vietnam's top Sustainable Companies in 2020
14-12-2020 19:27
Traphaco JSC was last week honoured with the Top 100 Sustainable Companies of Vietnam in 2020.
Traphaco breaks path for Pharma 4.0 for Vietnam
05-12-2020 11:25
The pharmaceutical sector has very specific characteristics with which all players need to fall in line. Manufacturing relies mainly on machines with stringent hygienic standards across all stages of production. The industry not only requires traceability and strict shelf-life management but also extremely high accuracy. All in all, it is the perfect industry to benefit from digitalisation throughout production and management alike, putting consumers’ minds at ease about the safety and reliability of the medicine and freeing them from the need to spend time to collect information.
Traphaco looking steady at threshold into 2021
27-11-2020 09:20
Leading drug maker Traphaco and its three drug brands – hepatobiliary tonic Boganic, brain tonic Hoat huyet duong nao, and cerebral tonic Cebraton – was honoured by the Vietnamese prime minister for the fifth consecutive years at the National Brand Awards on November 25.
Traphaco ahead the revenue and profit curve after nine months
26-10-2020 16:08
After completing 65 per cent of its revenue plan and 78.5 per cent of its profit plan in the first nine months, Traphaco (TRA) forecast fruitful business results as the fouth quarter is ususally the peak season accounting for a large portion of its revenue and profit.
Ups and downs in pharma industry due to crucial supply chain hiccups
14-07-2020 15:00
After months of challenges and faults in the global ingredient supply chain, peaks and valleys are the landscape for Vietnamese drug giants in their first-half performance, and several factors remain that could damage their operational prospects in the months to come.
Drugmakers tackling disrupted supply chain
24-04-2020 11:00
While gaining advantage in the first quarter of 2020 amid the coronavirus outbreak, Vietnamese drug giants are predicted to face challenges in the upcoming months due to faults in the global ingredient supply chain.
Pharma landscape set for shake-up
11-03-2020 11:00
Facing significant expansion from multinational corporations, Vietnamese drug giants took a hit in 2019 despite new strategies, signalling an uninspiring outlook for future growth.
Mobile Version